Innovator Biocon Battles India's Reputation To Develop New Drugs
This article was originally published in PharmAsia News
Executive Summary
The head of Biocon said it and other India pharmaceutical innovators still face stiff challenges in developing new drugs, part of it discrimination by local physicians in choosing clinical trials to work on.